131 related articles for article (PubMed ID: 38769456)
21. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
Oda K; Jono H; Nosaka K; Saito H
Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the appropriateness of vancomycin therapeutic drug monitoring in the intensive care unit with a clinical pharmacy approach, a cross-sectional study.
Dinçel S; Demirpolat E
Eur J Hosp Pharm; 2024 Jun; ():. PubMed ID: 38834285
[TBL] [Abstract][Full Text] [Related]
23. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.
Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ
Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425
[TBL] [Abstract][Full Text] [Related]
24. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
25. Evaluation by N-terminal prohormone of brain natriuretic peptide concentrations and ross scoring of the efficacy of digoxin in the treatment of heart failure secondary to congenital heart disease with left-to-right shunts.
Elkiran O; Sandikkaya A; Kocak G; Karakurt C; Taskapan C; Yologlu S
Pediatr Cardiol; 2013 Oct; 34(7):1583-9. PubMed ID: 23483243
[TBL] [Abstract][Full Text] [Related]
26. A Moving Target-Vancomycin Therapeutic Monitoring.
Burns AN; Goldman JL
J Pediatric Infect Dis Soc; 2020 Sep; 9(4):474-478. PubMed ID: 32716487
[TBL] [Abstract][Full Text] [Related]
27. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
[TBL] [Abstract][Full Text] [Related]
28. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
Xu G; Chen E; Mao E; Che Z; He J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
[TBL] [Abstract][Full Text] [Related]
29. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
Shenkman HJ; Zareba W; Bisognano JD
Am J Cardiol; 2007 Apr; 99(8):1143-5. PubMed ID: 17437744
[TBL] [Abstract][Full Text] [Related]
30. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
Reilly AM; Ding MX; Rower JE; Kiser TH
J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin.
Iwamoto T; Kagawa Y; Kojima M
Biol Pharm Bull; 2003 Jun; 26(6):876-9. PubMed ID: 12808304
[TBL] [Abstract][Full Text] [Related]
32. A retrospective analysis of vancomycin pharmacokinetics in Japanese cancer and non-cancer patients based on routine trough monitoring data.
Omote S; Yano Y; Hashida T; Masuda S; Yano I; Katsura T; Inui K
Biol Pharm Bull; 2009 Jan; 32(1):99-104. PubMed ID: 19122288
[TBL] [Abstract][Full Text] [Related]
33. Association of Initial Trough Concentrations of Vancomycin with Outcomes in Pediatric Patients with Gram-Positive Bacterial Infection.
Kondo M; Nakagawa S; Orii S; Itohara K; Sugimoto M; Omura T; Sato Y; Imai S; Yonezawa A; Nakagawa T; Matsubara K
Biol Pharm Bull; 2020; 43(10):1463-1468. PubMed ID: 32999156
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock.
Varpula M; Pulkki K; Karlsson S; Ruokonen E; Pettilä V;
Crit Care Med; 2007 May; 35(5):1277-83. PubMed ID: 17414731
[TBL] [Abstract][Full Text] [Related]
35. Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations.
Wang L; Lin X; Wang L; Ye H; Lin Y; Ruan J; Shi S
Int J Clin Pharm; 2022 Dec; 44(6):1325-1331. PubMed ID: 36136207
[TBL] [Abstract][Full Text] [Related]
36. Pediatric vancomycin dosing: Trends over time and the impact of therapeutic drug monitoring.
Balch AH; Constance JE; Thorell EA; Stockmann C; Korgenski EK; Campbell SC; Spigarelli MG; Sherwin CM
J Clin Pharmacol; 2015 Feb; 55(2):212-20. PubMed ID: 25264036
[TBL] [Abstract][Full Text] [Related]
37. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
AbuSara AK; Abdelrahman DH; Habash KI; Al-Shaer MH; Le J; Nazer LH
Pharmacol Res Perspect; 2022 Feb; 10(1):e00912. PubMed ID: 34990089
[TBL] [Abstract][Full Text] [Related]
38. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
[TBL] [Abstract][Full Text] [Related]
39. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
[TBL] [Abstract][Full Text] [Related]
40. Large-Scale Variability of Inpatient Tacrolimus Therapeutic Drug Monitoring at an Academic Transplant Center: A Retrospective Study.
Strohbehn GW; Pan WW; Petrilli CM; Heidemann L; Larson S; Aaronson KD; Johnson M; Ellies T; Heung M
Ther Drug Monit; 2018 Aug; 40(4):394-400. PubMed ID: 29750738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
